Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement Investigational Device Exemption

NCT04717570 is registered in ClinicalTrials.gov with Foldax, Inc as lead sponsor.

NCT NCT04717570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement Investigational Device Exemption
Lead sponsor
Foldax, Inc
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2021
Completion date
December 31, 2025
Enrollment
15 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve disease, mitral valve failure, mitral valve stenosis